Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dydrogesterone versus vaginal micronized progesterone for luteal support in IVF
2012-002215-26Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in female infertility comparing Oral dydrogesterone with Intravaginal micronized progesterone (2 arms). Primary endpoint: Pregnancy rate at 12 weeks' gestation. Started Mar 2013; status: completed.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
female infertility
Beyond the preview
Go deeper on 2012-002215-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002215-26.